119-HR-6401 Journalist Public Summary

Public Summary: Increasing Medication Access for Seniors Act of 2025 (H.R. 6401)

Headline Summary: A bipartisan bill to make HHS report, on a set schedule, how many Medicare Part D enrollees are choosing the monthly capped payment option and how well CMS is promoting it. [1]Congress.gov / Library of Congress — H.R. 6401 — Increasing Medication Access f…

What It Does: H.R. 6401 orders HHS to submit reports starting 3 months after enactment, quarterly during the first year, then annually through March 31, 2031. Reports must include: how many people elected the option (by region and by plan type), estimates of who might benefit but didn’t opt in, progress toward allowing election at the pharmacy counter (point‑of‑sale), and details on outreach via Medicare.gov, the Medicare & You handbook, 1‑800‑MEDICARE, provider resources, and other stakeholder efforts. [1]Congress.gov / Library of Congress — H.R. 6401 — Increasing Medication Access f…

Why It Matters: Beginning in 2025, the Medicare Prescription Payment Plan lets Part D enrollees spread their out‑of‑pocket drug costs into capped monthly bills instead of large lump sums at the pharmacy; at the same time, Part D now has a $2,000 annual cap on out‑of‑pocket costs. Tracking who uses the monthly option and where awareness is lagging can help target fixes that make medicines more affordable and budgeting more predictable for seniors. [3]Centers for Medicare & Medicaid Services — Medicare Prescription Payment Plan o…[2]Centers for Medicare & Medicaid Services — CMS fact sheet: 2025 Medicare Advant…

Who’s For It:

• Sponsors: Rep. Jennifer Kiggans (R‑VA) and Rep. Raja Krishnamoorthi (D‑IL) say the goal is to help seniors manage high drug costs and to boost awareness through better reporting. [1]Congress.gov / Library of Congress — H.R. 6401 — Increasing Medication Access f…[5]U.S. House of Representatives (Rep. Kiggans) — Rep. Kiggans press page: What Th…
• Patient and aging groups expressing support/endorsements include Genetic Alliance, PAN Foundation, Alliance for Aging Research (LOOP Coalition), Lupus Foundation of America, Alpha‑1 Foundation, and NANASP, citing the value of “smoothing” costs and transparent uptake data. [5]U.S. House of Representatives (Rep. Kiggans) — Rep. Kiggans press page: What Th…

Who’s Against It (or raising concerns):

• Implementation cautions: stakeholder groups have urged CMS to move carefully as multiple Medicare Part D/MA changes roll out, emphasizing stability and avoiding added burdens. [6]Better Medicare Alliance — Better Medicare Alliance statement urging stability…
• Analysts flag potential risks in the underlying monthly‑payment program, such as disenrollment for missed payments and plans absorbing unpaid balances—issues reporting could help monitor. [4]Legal Information Institute (Cornell Law School) — 42 U.S.C. § 1395w‑102 (Part…[7]University of Pennsylvania (Leonard Davis Institute of Health Economics) — Penn…
• CMS has been issuing step‑by‑step guidance (including pharmacy processes), so some debate may focus on timing and mechanics rather than on collecting data. [8]Centers for Medicare & Medicaid Services — CMS press release: Draft guidance fo…

What’s Next: The bill was introduced on December 3, 2025 and referred to the House Energy and Commerce and Ways and Means committees; it would need committee action before any House floor vote. [1]Congress.gov / Library of Congress — H.R. 6401 — Increasing Medication Access f…

Tone: Neutral, plain‑English overview for general readers.